Technology area: Biotechnology & Pharmaceuticals
52 pending office actions • 39 clients • 49 examiners • 42 art units • 0 of 52 (0%) have an AI response strategy ready
KAGAN BINDER, PLLC has 56 pending office actions in Biotechnology & Pharmaceuticals and 2673 career applications. Its resolved allowance rate is 81.5%, and the average office actions per allowance is 3.78. The profile combines a substantial active workload with a sizeable recorded application history.
The allowance rate applies to resolved matters, while pending actions identify current prosecution work. The office-action average indicates that allowance has generally followed repeated examination activity in the historical record. Practitioners can use the data for workload planning, but should assess each biotechnology or pharmaceutical matter through its claim construction, technical support, cited art, and available amendment options.
Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 6 (12%) |
| §103 only | 10 (19%) |
| §102 only | 3 (6%) |
| §112 only | 5 (10%) |
| Double-patenting only | 1 (2%) |
| Double-patenting + other | 3 (6%) |
| Multi-statute (no §101) | 24 (46%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOLLAND, PAUL J | 2 | 57.3% | +64.7% |
| HENSON, KATINA N | 2 | 56.8% | +31.5% |
| QIAN, CELINE X | 2 | 47.5% | +17.2% |
| HUTCHINSON, ALAN D | 1 | 78.9% | +16.8% |
| BUCK, MATTHEW R | 1 | 83.3% | +14.4% |
| RUNYAN, SILVANA C | 1 | 82.5% | +17.0% |
| LUCCHESI, NICHOLAS D | 1 | 78.4% | +9.5% |
| HERNANDEZ, JACKSON J | 1 | 50.7% | +39.2% |
| WHALEY, PABLO S | 1 | 25.0% | +21.3% |
| KIM, SAMUEL CHONG | 1 | 49.2% | +69.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19234843 | ELUTION SYSTEMS FOR TREATMENT OF SUBTERRANEAN RESERVOIRS | BUCK, MATTHEW R | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17413468 | BARN DUST EXTRACT FOR THE PREVENTION AND TREATMENT OF DISEASES | BENAVIDES, JENNIFER ANN | 113d overdue |
| 18572315 | Crumble feed formulation for ruminant animals and method for preparing said crumble feed formulation | MCNEIL, JENNIFER C | 87d overdue |
| 18033524 | IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING NON-MELANOMA SKIN CANCER | ABBAS, SYED JARAR | 73d overdue |
| 18277041 | PATIENT SELECTION FOR TREATMENT WITH DENDRITIC CELL VACCINATION | JUEDES, AMY E | 30d overdue |
| 18702276 | PROCESS FOR COATING A GRANULAR MATERIAL, COATED GRANULAR MATERIAL AND KIT | WALTERS JR, ROBERT S | 3d overdue |
| 18085952 | DEGRADABLE FISHING LINES AND NETS | XU, JIANGTIAN | 2d overdue |
| 18709148 | SEQUENCE FOR PROTEIN DECAY | PAK, YONG D | 22d |
| 18020915 | AMINO-MODIFIED CHIP, PREPARATION METHOD THEREFOR AND USE THEREOF | CROW, ROBERT THOMAS | 29d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18880793 | SURFACE TREATMENT METHOD, SEQUENCING METHOD, AND KIT | HERNANDEZ, JACKSON J | 30d overdue |
| 17252565 | Dissolvable Wet Wipe | HENSON, KATINA N | 54d |
| 19289333 | METHOD FOR CONTROLLING A BICYCLE CONFIGURATION | HUTCHINSON, ALAN D | — |
| 19234843 | ELUTION SYSTEMS FOR TREATMENT OF SUBTERRANEAN RESERVOIRS | BUCK, MATTHEW R | — |
| 19095272 | COMPOSITIONS AND METHODS FOR CONTROLLING ASPHALTENE DEPOSITION | RUNYAN, SILVANA C | — |
| 18999061 | METHOD AND APPARATUS FOR DETECTING CHROMOSOMAL ANEUPLOIDY, DEVICE AND STORAGE MEDIUM | WHALEY, PABLO S | — |
| 18877076 | BIOMETRIC SENSORS | KIM, SAMUEL CHONG | — |
| 18329503 | MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES | HOLLAND, PAUL J | — |
| Art Unit | Apps |
|---|---|
| 1652 | 4 |
| 3723 | 3 |
| 1684 | 2 |
| 1638 | 2 |
| 1656 | 2 |
| 1675 | 2 |
| 1637 | 2 |
| 3669 | 1 |
| 3672 | 1 |
| 3674 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19289333 | METHOD FOR CONTROLLING A BICYCLE CONFIGURATION | Ohlins Group AB | HUTCHINSON, ALAN D | 3669 | DP | Non-Final OA | — | Pending | Aug 04, 2025 |
| 19234843 | ELUTION SYSTEMS FOR TREATMENT OF SUBTERRANEAN RESERVOIRS | Championx LLC | BUCK, MATTHEW R | 3672 | §102Other | Non-Final OA | — | Pending | Jun 11, 2025 |
| 19095272 | COMPOSITIONS AND METHODS FOR CONTROLLING ASPHALTENE DEPOSITION | Championx LLC | RUNYAN, SILVANA C | 3674 | §102§103 | Final Rejection | — | Pending | Mar 31, 2025 |
| 19107708 | IMPRESSION MAKING SYSTEM FOR THE MANUFACTURE OF REMOVABLE DENTAL PROSTHESES | Laboratorio Digital High Teeth, S.L. | LUCCHESI, NICHOLAS D | 3772 | §102§112 | Non-Final OA | — | Pending | Feb 28, 2025 |
| 18880793 | SURFACE TREATMENT METHOD, SEQUENCING METHOD, AND KIT | Genemind Biosciences Co., Ltd. | HERNANDEZ, JACKSON J | 1627 | §112 | Final Rejection | 30d overdue | Pending | Jan 02, 2025 |
| 18999061 | METHOD AND APPARATUS FOR DETECTING CHROMOSOMAL ANEUPLOIDY, DEVICE AND STORAGE MEDIUM | Genemind Biosciences Co., Ltd. | WHALEY, PABLO S | 3619 | §101§102§112 | Non-Final OA | — | Pending | Dec 23, 2024 |
| 18877076 | BIOMETRIC SENSORS | Sm24 Ltd. | KIM, SAMUEL CHONG | 3791 | §102§103§112 | Non-Final OA | — | Pending | Dec 19, 2024 |
| 18952145 | COMBINED EVENT DRIVER AND FINANCIAL CARD | Veritec, Inc. | FRANKLIN, JAMARA ALZAIDA | 2876 | §102§112 | Non-Final OA | 43d | Pending | Nov 19, 2024 |
| 18950631 | METHOD AND APPARATUS FOR DETERMINING INTER-CHANNEL CROSSTALK CORRECTION STRENGTH, AND MEDIUM | Genemind Biosciences Co., Ltd. | MILIA, MARK R | 2681 | §103 | Non-Final OA | — | Pending | Nov 18, 2024 |
| 18937498 | N-CONTAINING/HUMIC FERTILIZER AND PREPARING METHODS THEREOF | Huma, Inc. | PACKARD, BENJAMIN J | 1612 | §102§103 | Non-Final OA | — | Pending | Nov 05, 2024 |
| 18798368 | IMAGING SYSTEM AND SEQUENCING SYSTEM | Genemind Biosciences Co., Ltd. | MERLIN, JESSICA M | 2871 | §103 | Final Rejection | — | Pending | Aug 08, 2024 |
| 18834180 | CARBON BRUSH AND METHOD OF SUPPLYING POWER TO A CARBON BRUSH SENSOR | AB Dynamoborstfabriken | HARCUM, MARCUS E | 2831 | §102 | Non-Final OA | — | Pending | Jul 29, 2024 |
| 18776917 | BUFFER FOR FEMORAL HEAD AND NECK EXCISION | Idr-Biomed Ltd. | MATHEW, SEEMA | 3774 | §102§103§112 | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18709148 | SEQUENCE FOR PROTEIN DECAY | TriTerp | PAK, YONG D | 1652 | §102§103§112 | Final Rejection | 22d | Pending | May 10, 2024 |
| 18652140 | METHOD FOR RECOVERING VALUABLE METALS FROM SPENT CATALYSTS | Kenit International, Inc. | WANG, NICHOLAS A | 1734 | §102§103§112 | Non-Final OA | — | Pending | May 01, 2024 |
| 18702276 | PROCESS FOR COATING A GRANULAR MATERIAL, COATED GRANULAR MATERIAL AND KIT | Ask Chemicals GmbH | WALTERS JR, ROBERT S | 1717 | §102§103 | Non-Final OA | 3d overdue | Pending | Apr 17, 2024 |
| 18701537 | HLA GENE AMPLIFICATION PRIMER, KIT, SEQUENCING LIBRARY CONSTRUCTION METHOD, AND SEQUENCING METHOD | Xi'An Haorui Gene Technologies Ltd. | TSUI, YUNG-SHENG M | 1684 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 15, 2024 |
| 18686841 | IN VITRO METHOD OF INVASIVE AND DUCTAL CELL GROWTH | Technische Universität München | WESTON, ALYSSA G | 1633 | §102§103 | Final Rejection | — | Pending | Feb 26, 2024 |
| 18686220 | BRUSH FOR MAINTENANCE OF INDOOR AND OUTDOOR PADEL TURFS | Padmax Group AB | HORTON, ANDREW ALAN | 3723 | §103 | Final Rejection | 7d | Pending | Feb 23, 2024 |
| 18683180 | IL-2/IL-15RBETAGAMMA AGONIST COMBINATION WITH ANTIBODY-DRUG CONJUGATES FOR TREATING CANCER | Cytune Pharma | BEANE, RANDALL L | 1654 | §103§112Other | Non-Final OA | — | Pending | Feb 12, 2024 |
| 18403262 | CRUDE STEROL AS AN ADDITIVE IN ASPHALT BINDER | Ergon Asphalt & Emulsions, Inc. | MERKLING, SALLY ANNE | 1738 | §103§112DP | Non-Final OA | — | Pending | Jan 03, 2024 |
| 18572315 | Crumble feed formulation for ruminant animals and method for preparing said crumble feed formulation | Graincorp Limited | MCNEIL, JENNIFER C | 1793 | §102§103 | Final Rejection | 87d overdue | Pending | Dec 20, 2023 |
| 18570632 | CLASSIFICATION USING ARTIFICIAL INTELLIGENCE STRATEGIES THAT RECONSTRUCT DATA USING COMPRESSION AND DECOMPRESSION TRANSFORMATIONS | Microtrace, LLC | HASTY, NICHOLAS | 2141 | §101§102§103 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18563218 | SEQUENCING METHOD | Genemind Biosciences Company Limited | FLINDERS, JEREMY C | 1684 | §102§103§112 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18562690 | SNUS CONTAINER | SÄVJO PLASTIC AB | REYNOLDS, STEVEN ALAN | 3735 | §103 | Final Rejection | — | Pending | Nov 20, 2023 |
| 18388057 | TOPICAL COMPOSITION CONTAINING CANNABINOIDS | Tf Holdings LLC | AGGARWAL, SAHIL CHANDER | 1623 | §103 | Final Rejection | — | Pending | Nov 08, 2023 |
| 18289283 | COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | SAMSELL, RILLA MARIE | 1624 | §103§112DP | Non-Final OA | — | Pending | Nov 02, 2023 |
| 18287437 | A METHOD AND DEVICE FOR PRODUCING A PRODUCT COMPRISING A SUBSTRATE WITH AT LEAST ONE PATTERNED LAYER | Dp Patterning AB | ABRAHAM, JOSE K | 3729 | §103§112 | Non-Final OA | — | Pending | Oct 18, 2023 |
| 18280908 | VACCINE COMPOSITIONS AND METHODS FOR TREATING HSV | Redbiotec AG | GRIZER, CASSANDRA SENN | 1672 | §101§103§112DP | Non-Final OA | — | Pending | Sep 07, 2023 |
| 18242912 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | Genomatica, Inc. | RAMIREZ, DELIA M | 1652 | §102§112 | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18277535 | POLYSACCHARIDE COMPLEX | Acaryon GmbH | BRANDSEN, BENJAMIN MICHAEL | 1693 | §102§103§112 | Non-Final OA | — | Pending | Aug 16, 2023 |
| 18277041 | PATIENT SELECTION FOR TREATMENT WITH DENDRITIC CELL VACCINATION | Sctbio A.S. | JUEDES, AMY E | 1644 | §101§102§112Other | Non-Final OA | 30d overdue | Pending | Aug 11, 2023 |
| 18228881 | WOUND TREATMENT TOPICAL COMPOSITION CONTAINING CANNABINOIDS | Tf Holdings LLC | WARD, PAUL V | 1622 | §102 | Non-Final OA | — | Pending | Aug 01, 2023 |
| 18270154 | EPOXY RESIN COMPOSITION AND TRANSPARENT COMPOSITE MATERIAL COMPRISING SAME, AND LAMINATED BOARD | Guangdong Hinno-Tech Co., Ltd. | HESTER, HOLLEY GRACE | 1766 | §103 | Non-Final OA | 23d | Pending | Jun 28, 2023 |
| 18268948 | APPLICATION OF CRISPR/CAS13 FOR THERAPY OF RNA VIRUS AND/OR BACTERIUM INDUCED DISEASES | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | MOAZZAMI, NAGHMEH NINA | 1652 | §103DP | Final Rejection | 9d | Pending | Jun 21, 2023 |
| 18265857 | EXOGENOUS GENE CONTROLLABLE EXPRESSION VIRUS PACKAGING VECTOR AND PACKAGING METHOD | Obio Technology (Shanghai) Corp., Ltd. | MCCORMICK, CATHERINE LYNN | 1638 | §103 | Final Rejection | — | Pending | Jun 07, 2023 |
| 18265820 | LENTIVIRUS VECTOR WITH CONTROLLABLE EXPRESSION OF GENE OF INTEREST, AND PACKAGING METHOD THEREFOR | Obio Technology (Shanghai) Corp., Ltd. | JOHNSON, ALLISON MARIE | 1638 | §102§103§112 | Final Rejection | 62d | Pending | Jun 07, 2023 |
| 18329503 | MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES | Octapharma AG | HOLLAND, PAUL J | 1656 | §112 | Non-Final OA | — | Pending | Jun 05, 2023 |
| 18329520 | MEANS AND METHODS FOR MODIFYING MULTIPLE ALLELES | Octapharma AG | HOLLAND, PAUL J | 1656 | §112 | Non-Final OA | — | Pending | Jun 05, 2023 |
| 18039060 | TCR CAPABLE OF RECOGNIZING HPV ANTIGEN | Xlifesc, Ltd. | PETERS, ALEC JON | 1641 | §112 | Non-Final OA | 15d | Pending | May 26, 2023 |
| 18033773 | IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING SQUAMOUS CELL CARCINOMA | Cytune Pharma | CESARE, JOSEPH DAVID | 1675 | §103 | Final Rejection | — | Pending | Apr 25, 2023 |
| 18033524 | IL-2/IL-15R-BETA-GAMMA AGONIST FOR TREATING NON-MELANOMA SKIN CANCER | Cytune Pharma | ABBAS, SYED JARAR | 1674 | §102§112Other | Non-Final OA | 73d overdue | Pending | Apr 24, 2023 |
| 18020915 | AMINO-MODIFIED CHIP, PREPARATION METHOD THEREFOR AND USE THEREOF | Genemind Biosciences Co., Ltd. | CROW, ROBERT THOMAS | 1682 | §103§112 | Non-Final OA | 29d | Pending | Feb 10, 2023 |
| 18085952 | DEGRADABLE FISHING LINES AND NETS | Enviro Cast, LLC | XU, JIANGTIAN | 1762 | §103§112 | Final Rejection | 2d overdue | Pending | Dec 21, 2022 |
| 18083154 | DISSOLVABLE WET WIPE | Mccormack Innovation Limited | HENSON, KATINA N | 3723 | §103§112 | Final Rejection | — | Pending | Dec 16, 2022 |
| 18010407 | CELL-MEDIATED SARS-COV-2 VACCINES, AND PREPARATION AND USE THEREOF | Xiushan Yin | QIAN, CELINE X | 1637 | §103 | Final Rejection | — | Pending | Dec 14, 2022 |
| 17920606 | COMPOSITION COMPRISING A DNA-DEGRADING ENZYME FOR USE IN A METHOD FOR THE TREATMENT OF IMMUNOSUPPRESSION AFTER ACUTE TISSUE INJURY | Klinikum Der Universität München | SWIFT, CANDICE LEE | 1657 | §102§112 | Final Rejection | — | Pending | Oct 21, 2022 |
| 17843589 | NON-NATURAL MICROBIAL ORGANISMS WITH IMPROVED ENERGETIC EFFICIENCY | Genomatica, Inc. | ROBINSON, HOPE A | 1652 | §112 | Final Rejection | 31d overdue | Pending | Jun 17, 2022 |
| 17780421 | ENGINEERED CELLS FOR PRODUCTION OF CANNABINOIDS AND OTHER MALONYL-CoA-DERIVED PRODUCTS | Genomatica, Inc. | QIAN, CELINE X | 1637 | §103§112 | Non-Final OA | — | Pending | May 26, 2022 |
| 17634117 | WEARABLE SENSOR DEVICE | Onera Technologies B.V. | ROBINSON, NICHOLAS A | 3798 | §101§103 | Non-Final OA | — | Pending | Feb 09, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial81.5% of resolved applications prosecuted by Kagan Binder, Pllc were allowed, across 2,673 applications in USPTO records.
3.78 office actions per allowed application on average.
52 pending office actions as of October 2026, for 39 clients, before 49 examiners in 42 art units.
